natgillin/translations-raw huggingface dataset:
Overall, the results of the dosimetric analysis performed in the NETTER-1 phase III dosimetry substudy and in the Erasmus phase I/II study are in agreement and indicate that Lutathera dose regimen (4 administrations of 7,400 MBq) is safe. 
faze skladni in kažejo, da je režim odmerjanja zdravila Lutathera (4 aplikacije po 7.400 MBq) varen.
• Bone metastasis; 
- če imate metastaze v kosteh;
Bronchial Pancreatic Foregut** Midgut Hindgut 
Bronhialni Pankreatski
Please see Table 5 in case of dose modifying toxicity. 
v primeru toksičnosti, ki zahteva prilagoditev odmerka.
Lutetium-177 (177Lu) is a β- emitting radionuclide with a maximum penetration range in tissue of 
Lutecij (177Lu) razpade z emisijo β- na stabilni hafnij
How Lutathera is stored 
Shranjevanje zdravila Lutathera
Oropharyngeal pain Pleural effusion Sputum increased Choecking sensation 
Plevralni izliv Povečano nastajanje izpljunka
Hepatobiliary disorders 
Hemoragični ascites
Any other CTCAE grade 3 or grade 4 toxicity** possibly related to Lutathera. 
Vsaka druga toksičnost CTCAE 3. ali 4.
Table 5. 
Glejte preglednico 5
Biodistribution studies show that lutetium (177Lu) 
faze in NETTER-1 III. faze, se lutecijev (177Lu)
Hindgut 
Merilo
Hepatic congestion Hepatic failure 
Zardevanje Vročinski obliv Hipotenzija
Acute kidney injury Haematuria Renal failure Proteinuria 
Akutna poškodba ledvic Hematurija
Blood potassium decreased Blood urea increased Glycosylated haemoglobin increased 
Zvečanje vrednosti glikiranega hemoglobina
Leukocyturia 
Vranica
Do not give this medicine to children (under 12 years of age) because it does not work. 
Ne dajajte tega zdravila otrokom ali mladostnikom (starim manj kot 12 let), ker ne deluje.
Krka, d.d., Novo mesto Šmarješka cesta 6 
KRKA, d.d., Novo mesto - Locna Šmarješka cesta 6
None of these analyses were adequately sized to detect differences in outcome in poor metabolisers. 
Nobena teh analiz ni imela zadostne velikosti za odkritje razlik v izidu pri slabih metabolizatorjih
- a planned surgery (including dental) in the next seven days. 
- načrtovan kirurški poseg (tudi na zobeh) v naslednjih sedmih dneh;
The expiry date refers to the last day of that month. 
Roka uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Macrogol 3000 
smukec makrogol 3000
Their frequency is defined using the following conventions: common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data). 
Njihova pogostnost je navedena po naslednjem dogovoru: pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki (<1/10.000), neznani (ni mogoče oceniti iz razpoložljivih podatkov).
Clopidogrel has been evaluated for safety in more than 44,000 patients who have participated in clinical studies, including over 12,000 patients treated for 1 year or more. 
Varnost klopidogrela so vrednotili pri več kot 44.000 bolnikih, ki so sodelovali v kliničnih študijah, vključno z več kot 12.000 bolniki, ki so se zdravili eno leto ali več.
Date of first authorisation: 28 October 2010 Date of latest renewal: 16 June 2015 
Datum pridobitve dovoljenja za promet: 28.10.2010 Datum zadnjega podaljšanja: 16.06.2015
Excipients with known effect: 
Pomožna snov z znanim učinkom:
Acetylsalicylic acid (ASA) 
Acetilsalicilna kislina (ASA)
Do not use this medicine after the expiry date which is stated on the carton and on the blister, after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake EXP.
Some other medicines may influence the use of Clopidogrel HCS or vice versa. 
Nekatera druga zdravila lahko vplivajo na jemanje zdravila Klopidogrel HCS in obratno.
Not applicable. 
nista funkcionalna.
You should take Clopidogrel HCS for as long as your doctor continues to prescribe it. 
Zdravilo Klopidogrel HCS morate jemati, dokler vam ga vaš zdravnik predpisuje.
This may cause stomach upset or diarrhoea. 
To lahko povzroči želodčne motnje ali drisko.
This leaflet was last revised in <Month YYYY>. 
Navodilo je bilo nazadnje revidirano dne < mesec LLLL>
However, clopidogrel and ASA have been administered together for up to one year (see section 
Vendar pa so klopidogrel in ASA sočasno jemali do eno leto (glejte poglavje
-4.0%; CI: -22.5 to 11.7 [p=0.639]). 
IZ: -22,5 do 11,7 /p = 0,639/).
The film-coated tablets are pink, round and slightly convex. 
Filmsko obložente tablete so rožnate, okrogle in rahlo izbočene.
HCS bvba H. Kennisstraat 53 B-2650 Edegem Belgium 
HCS bvba H. Kennisstraat 53 B-2650 Edegem Belgija
Side effects with frequency not known (frequency cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain. 
Neželeni učinki z neznano pogostnostjo (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti): Preobčutljivostne reakcije z bolečinami v prsih ali trebuhu.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. 
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katerokoli zdravilo, tudi če ste ga dobili brez recepta.
The ACTIVE-W and ACTIVE-A studies, separate trials in the ACTIVE program, included patients with atrial fibrillation (AF) who had at least one risk factor for vascular events. 
Atrijska fibrilacija Študiji ACTIVE-W in ACTIVE-A, ločeni preskušanji v programu ACTIVE, sta vključili bolnike z atrijsko fibrilacijo (AF), ki so imeli vsaj en dejavnik tveganja za žilne dogodke.
If you experience prolonged bleeding when taking Plavix If you cut or injure yourself, it may take longer than usual for bleeding to stop. 
Če doživite podaljšanje krvavitve v času jemanja zdravila Klopidogrel HCS Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se krvavitev ustavi.
In CURE, 823 (6.6%) patients received concomitant GPIIb/IIIa receptor antagonist therapy. 
V študiji CURE je 823 (6,6%) bolnikov sočasno prejemalo terapijo z antagonisti receptorjev glikoproteinov IIb/IIIa.
Other alleles associated with absent or reduced metabolism are less frequent and include CYP2C19*4, *5, *6, *7, and *8. 
Drugi aleli, povezanimi z odstotno ali zmanjšano presnovo, so redkejši in vključujejo CYP2C19*4, *5, *6, *7 in
After single and repeated oral doses of 75 mg per day, clopidogrel is rapidly absorbed. 
Po enkratnem in večkratnih peroralnih odmerkih po 75 mg na dan se klopidogrel hitro absorbira
What Clopidogrel HCS is and what it is used for 
Kaj je zdravilo Klopidogrel HCS in za kaj ga uporabljamo
The MAH must ensure that the system of pharmacovigilance, presented in Module 1.8.1 of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market. 
Imetnik dovoljenja za promet z zdravilom mora zagotoviti, da je sistem farmakovigilance je predstavljen v Modulu 1.8.1. pridobitve dovoljenja za promet z zdravilom, vzpostavljen in deluje,
Seventy-three percent (73%) of patients enrolled into the ACTIVE-A study were unable to take VKA due to physician assessment, inability to comply with INR (international normalised ratio) monitoring, predisposition to falling or head trauma, or specific risk of bleeding; for 26% of the patients, the physician's decision was based on the patient's unwillingness to take VKA. 
Triinsedemdeset odstotkov (73 %) bolnikov, vključenih v študijo ACTIVE-A, je bilo neprimernih za prejemanje VKA po zdravnikovi oceni, nezmožnosti upoštevanja kontrol INR (internacionalnega normaliziranega razmerja), nagnjenosti k padcem ali poškodbe glave, ali specifičnega tveganja krvavitev; pri 26 % bolnikov je zdravnikova odločitev temeljila na tem, da bolnik ni želel jemati
You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel HCS and acetylsalicylic acid for this condition. 
Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Klopidogrel HCS in acetilsalicilne kisline.
• Hypersensitivity to the active substance or to any of the excipients listed in section 2 or section 
• Preobčutljivost za zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 2
The population included 27.8% women, 58.4% patients ≥ 60 years (26% ≥ 70 years) and 54.5% patients who received fibrinolytics. 
Populacijo bolnikov je sestavljalo 27,8% žensk, 58,4% bolnikov starost ≥ 60 let (26% ≥ 70 let ) in 54,5% bolnikov, ki so dobivali fibrinolitike.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE 
B. POGOJI ALI OMEJITVE GLEDE OKRBE IN UPORABE
If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel HCS. 
Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden vzamete zdravilo Klopidogrel HCS.
The ACTIVE-A study (N=7,554) was a multicenter, randomized, double-blind, placebo-controlled study which compared clopidogrel 75 mg/day + ASA (N=3,772) to placebo + ASA (N=3,782). 
Študija ACTIVE-A (n = 7.554) je bila multicentrična, randomizirana, dvojno slepa, s placebom kontrolirana študija, ki je primerjala klopidogrel 75 mg/dan + ASA (n = 3.772) in placebo + ASA
In a dose escalation study of 86 neonates or infants up to 24 months of age at risk for thrombosis (PICOLO), clopidogrel was evaluated at consecutive doses of 0.01, 0.1 and 0.2 mg/kg in neonates and infants and 0.15 mg/kg only in neonates. 
Pediatrična populacija V študiji povečevanja odmerka, ki je zajela 86 novorojenčkov ali dojenčkov, starih do 24 mesecev, s tveganjem tromboze (PICOLO), so klopidogrel ocenili v zaporednih odmerkih 0,01, 0,1 in 0,2 mg/kg pri novorojenčkih in dojenčkih ter 0,15 mg/kg samo pri novorojenčkih.
The clinically relevant adverse reactions observed in the CAPRIE, CURE, CLARITY, COMMIT and ACTIVE-A studies are discussed below. 
Klinično pomembni neželeni učinki, zabeleženi v študijah CAPRIE, CURE, CLARITY, COMMIT in ACTIVE_A, so predstavljeni v nadaljevanju.
What Clopidogrel HCS is and what it is used for What you need to know before you take Clopidogrel HCS How to take Clopidogrel HCS Possible side effects 
Kaj je zdravilo Klopidogrel HCS in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzel zdravilo Klopidogrel HCS Kako jemati zdravilo Klopidogrel HCS
Pharmacotherapeutic group: platelet aggregation inhibitors excl. heparin, ATC Code: B01AC04. 
Farmakoterapevtska skupina: zaviralci agregacije trombocitov brez heparina, oznaka ATC: B01AC04.
Your doctor should have prescribed Clopidogrel HCS plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding. 
Zdravnik naj bi vam predpisal zdravilo Klopidogrel HCS skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
In patients who remained on therapy within five days of bypass graft surgery, the event rate was 9.6% for clopidogrel plus ASA, and 6.3% for placebo plus ASA. 
Pri bolnikih, ki so se zdravili do pet dni pred koronarno premostitveno operacijo, je bil delež dogodkov 9,6%% za klopidogrel in ASA in 6,3%% za placebo in ASA.
The incidence of severe cases was similar for clopidogrel and ASA. 
Incidenca hujših primerov krvavitev je bila podobna za klopidogrel in za ASA
Kounis syndrome (vasospastic allergic angina / allergic myocardial infarction) in the context of a hypersensitivity reaction due to clopidogrel* 
(vazospastična alergijska angina / alergijski miokardni infarkt) v okviru preobčutljivostne reakcije zaradi klopidogrela*
If you become pregnant while taking Clopidogrel HCS, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant. 
Če med zdravljenjem z zdravilom Klopidogrel HCS zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed clopidogrel in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever. 
Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali klopidogrel v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
• Adult patients suffering from acute coronary syndrome: - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). 
• odraslih bolnikih z akutnim koronarnim sindromom: Akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca), vključno z bolniki, katerim je bil vstavljen stent po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilno kislino (ASA - acetylsalicylic acid).
Contents of the pack and other information What Clopidogrel HCS contains 
Vsebina pakiranja in dodatene informacije Kaj vsebuje zdravilo Klopidogrel HCS
After repeated doses of 75 mg clopidogrel per day in subjects with severe renal disease (creatinine clearance from 5 to 15 ml/min), inhibition of ADP-induced platelet aggregation was lower (25%) than that observed in healthy subjects, however, the prolongation of bleeding time was similar to that seen in healthy subjects receiving 75 mg of clopidogrel per day. 
Po večkratnih odmerkih 75 mg klopidogrela na dan pri osebah s hudo ledvično boleznijo (kreatininski očistek 5-15 ml/min) inhibicija z ADP-jem sprožene agregacije trombocitov manjša (25%%) od tiste, opažene pri zdravih osebah.Vendar je bilo podaljšanje časa krvavitve podobno tistemu, ki so ga opazili pri zdravih osebah, ki so jemale 75 mg klopidogrela na dan.
Elimination Following an oral dose of 14C-labelled clopidogrel in man, approximately 50% was excreted in the urine and approximately 46% in the faeces in the 120-hour interval after dosing. 
Eliminacija Po peroralnem odmerku s 14C označenega klopidogrela pri človeku se ga je v 120-urnem intervalu po odmerjanju približno 50%% izločilo s sečem in približno 46% z blatom.
The safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thrombolytic agents and heparins was assessed in patients with acute myocardial infarction. 
Trombolitiki Varnost sočasnega jemanja klopidogrela, fibrinsko specifičnih ali fibrinsko nespecifičnih trombolitikov in heparinov je bila ovrednotena pri bolnikih z akutnim miokardnim infarktom.
Other medicines and Clopidogrel HCS 
Druga zdravila in zdravilo Klopidogrel HCS
Headache, stomach ulcer, vomiting, nausea, constipation, excessive gas in stomach or intestines, rashes, itching, dizziness, sensation of tingling and numbness. 
Glavobol, razjeda na želodcu, bruhanje, slabost, zaprtost, preveč plinov v želodcu ali črevesju, izpuščaji, srbenje, omotica, občutek mravljinčenja in otopelosti..
HCS bvba, H. Kennisstraat 53, B 2650 Edegem, Belgium 
Imetnik dovoljenja za promet: HCS bvba, H. Kennisstraat 53, B 2650 Edegem, Belgija
Driving and using machines Clopidogrel HCS is unlikely to affect your ability to drive or to use machines. 
Ni verjetno, da bi zdravilo Klopidogrel HCS vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
- efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections, - carbamazepine, a medicine to treat some forms of epilepsy, - moclobemide, medicine to treat depression, - repaglinide, medicine to treat diabetes, - paclitaxel, medicine to treat cancer. 
- efavirenz, zdravilo za zdravljenje infekcij z virusom HIV (virus humane imunske pomanjkljivosti), - karbamazepin, zdravilo za zdravljenje nekaterih oblik epilepsije, - moklobemid, zdravilo za zdravljenje depresije, - repaglinid, zdravilo za zdravljenje sladkorne bolezni, - paklitaksel, zdravilo za zdravljenje raka.
Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes in taste or loss of taste of food. 
Zlatenica, huda bolečina v trebuhu z bolečino v hrbtu ali brez nje, zvišana telesna temperatura, težave pri dihanju, ki so včasih povezane s kašljem, splošne alergijske reakcije (na primer, splošni občutek toplote z nenadnim nelagodjem do nezavesti), oteklina v ustih, mehurji na koži, kožna alergija, vnetje v ustih (stomatitis), znižanje krvnega tlaka, zmedenost, halucinacije, bolečine v sklepih, bolečine v mišicah, motnje v okušanju ali izguba okusa hrane.
The CYP2C19*1 allele corresponds to fully functional metabolism while the CYP2C19*2 and CYP2C19*3 alleles are nonfunctional. 
Alel CYP2C19*1 ustreza polno funkcionalni presnovi, medtem ko alela CYP2C19*2 in CYP2C19*3
Clopidogrel HCS contains hydrogenated castor oil 
Zdravilo Klopidogrel HCS vsebuje hidrogenirano ricinusovo olje
A total of 99.7% of patients received fibrinolytics (fibrin specific: 68.7%, non-fibrin specific: 31.1%), 89.5% heparin, 78.7% beta blockers, 54.7% ACE inhibitors and 63% statins. 
Skupno 99,7% bolnikov je dobivalo fibrinolitike (fibrinsko specifične: 68,7%, nefebrinsko specifične: 31,1%), 89,5% heparin, 78,7% zaviralce adrenergičnih receptorjev beta, 54,7% zaviralce ACE in 63 % statine.
In TRITON-TIMI 38 and 3 of the cohort studies (Collet, Sibbing, Giusti) the combined group of patients with either intermediate or poor metaboliser status had a higher rate of cardiovascular events (death, myocardial infarction, and stroke) or stent thrombosis compared to extensive metabolisers. 
V TRITON-TIMI 38 in 3 kohortnih študijah (Collet, Sibbing, Giusti) je imela kombinirana skupina bolnikov, ki so bili ali srednji ali slabi metabolizatorji, večji delež kardiovaskularnih dogodkov (smrt,
Very rare side effects (may affect up to 1 in 10,000 people): 
Zelo redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov):
The incidence of clinically significant bleeding was similar to that observed when thrombolytic agents and heparin are co-administered with ASA (see section 4.8) 
Incidenca klinično pomembnih krvavitev je bila podobna tisti, ki so jo opazili pri sočasnem jemanju trombolitikov in heparina ter ASA (glejte poglavje 4.8).
• Tablet coating: Polyvinyl alcohol, titanium dioxide (E171), red iron oxide (E172), yellow iron oxide (E172), talc and macrogol 3000. 
- Obloga tablete: polivinilalkohol, titanov dioksid (E171), rdeči železov oksid (E172), rumeni železov oksid (E172), smukec, in makrogol 3000.
In a clinical study conducted in healthy volunteers, the concomitant administration of clopidogrel and naproxen increased occult gastrointestinal blood loss. 
V klinični študiji, na zdravih prostovoljcih je sočasno jemanje klopidogrela in naproksena povečalo prikrito krvavitev iz prebavil.
Then, the recommended dose is one 75 mg tablet of Clopidogrel HCS per day as described above. 
Nato je priporočeni odmerek ena 75-mg tableta zdravila Klopidogrel HCS na dan, kot je opisano zgoraj.
In patients who were enrolled in the trial on the sole basis of a recent myocardial infarction, clopidogrel was numerically inferior, but not statistically different from ASA (RRR = 
Pri bolnikih, ki so bili v preizkušanje vključeni samo na podlagi nedavnega MI, je bil klopidogrel numerično inferioren, vendar se statistično ni razlikoval od ASA (zmanjšanje RT: -4%%;
CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A4. 
CYP, vključno s CYP1A2, CYP2B6 in CYP3A4.
Clopidogrel HCS contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products. 
Zdravilo Klopidogrel HCS vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
Respiratory tract bleeding (haemoptysis, pulmonary haemorrhage), bronchospasm, interstitial pneumonitis, eosinophilic pneumonia 
(hemoptiza, pljučna krvavitev), bronhospazem, intersticijski pnevmonitis, eozinofilna pljučnica
The use of clopidogrel in CURE was associated with a decrease in the need of thrombolytic therapy (RRR = 43.3%; CI: 24.3%, 57.5%) and GPIIb/IIIa inhibitors (RRR = 18.2%; CI: 6.5%, 28.3%). 
Uporaba klopidogrela v CURE je bila povezana z zmanjšano potrebo po zdravljenju s trombolitiki (zmanjšanje RT= 43,3%; IZ: 24,3%, 57,5%) in inhibitorji glikoproteinov IIb/IIIa (zmanjšanje RT =18,2%; IZ: 6,5%, 28,3%).
In a subgroup analysis by qualifying condition (myocardial infarction, ischaemic stroke, and PAD) the benefit appeared to be strongest (achieving statistical significance at p=0.003) in patients enrolled due to PAD (especially those who also had a history of myocardial infarction) (RRR = 23.7%; CI: 8.9 to 36.2) and weaker (not significantly different from ASA) in stroke patients (RRR = 7.3%; CI: -5.7 to 18.7 [p=0.258]). 
Pri analizi podskupin glede na vključitveni pogoj (MI, ishemična kap in PAD) je bila korist (doseganje statistične značilnosti pri p = 0,003) največja pri bolnikih, vključenih zaradi PAD (zlasti pri tistih, ki so doživeli tudi MI) (zmanjšanje RT: =23,7%; IZ: 8,9 do 36,2), in manjša (ni bila pomembno drugačna kot pri ASA) pri bolnikih s kapjo (zmanjšanje RT: 7,3%; IZ: -5,7 do 18,7 /p =
How to store Clopidogrel HCS Contents of the pack and other information 
Shranjevanje zdravila Klopidogrel HCS Vsebina pakiranja in dodatne informacije
The patient population included 19.7% women and 29.2% patients ≥65 years. 
Populacijo bolnikov je sestavljalo 19,7 % žensk in 29,2 %
In a clinical study conducted in healthy subjects, clopidogrel did not necessitate modification of the heparin dose or alter the effect of heparin on coagulation. 
V klinični študiji na zdravih osebah zaradi jemanja klopidogrela ni bilo treba spremeniti odmerka heparina, pa tudi učinek heparina na koagulacijo se ni spremenil.
Overall, clopidogrel 75 mg/day was comparable to ASA 325 mg/day in CAPRIE regardless of age, gender and race. 
V celoti je bil klopidogrel v odmerku 75 mg/dan v študiji CAPRIE, primerljiv z ASA v odmerku 325 mg/dan, ne glede na starost,
A total of 23.0% of patients received anti-arrhythmics, 52.1% beta-blockers, 54.6% ACE inhibitors, and 25.4% statins. 
V celoti je 23,0 % bolnikov prejemalo antiaritmike, 52,1 % blokatorje beta, 54,6 %
Patients should be told that it might take longer than usual to stop bleeding when they take clopidogrel (alone or in combination with ASA), and that they should report any unusual bleeding (site or duration) to their physician. 
ki je potreben za zaustavitev krvavitve, daljši kot ponavadi, in da morajo svojemu zdravniku poročati o kakršnikoli neobičajni krvavitvi (o mestu ali trajanju).
If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Plavix. 
Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta,
You have been prescribed Clopidogrel HCS to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or 
Zdravilo Klopidogrel HCS vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate otrdele arterije (znano tudi kot ateroskleroza), in
If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel HCS (4 tablets of 75 mg) once at the start of treatment. 
Če ste imeli hudo bolečino v prsih (nestabilna angina pektoris ali srčna kap), vam lahko zdravnik na začetku zdravljenja da enkrat 300 mg zdravila Klopidogrel HCS (štiri 75-mg tablete).